FDA inspection
Grifols Therapeutics Inc.: FDA inspection ending Mar 25, 2004
FDA inspection 319681 · Voluntary Action Indicated (VAI) · Raleigh, NC
Key facts
| Inspection ID | 319681 |
|---|---|
| Firm | Grifols Therapeutics Inc. |
| FEI number | 2077831 |
| Address | 1200 N New Hope Rd |
| City | Raleigh |
| State | NC |
| ZIP | 27610-1414 |
| Fiscal year | 2004 |
| Inspection end date | Mar 25, 2004 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood & Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data